School of Medicine
Showing 381-390 of 609 Results
-
Ruth O'Hara
Director, Spectrum, Senior Associate Dean, Research and Lowell W. and Josephine Q. Berry Professor
Current Research and Scholarly InterestsDr. O'Hara's research aims to investigate how cognitive information processing deficits subserve affective symptoms in psychiatric disorders, and interact with key brain networks integral to these disorders. To do so, she has implemented a translational, interdisciplinary program that encompasses cellular models, brain and behavioral assays of affective and cognitive information processing systems in psychiatric disorders across the lifespan.
-
Maurice M. Ohayon, MD, DSc, PhD
Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsMain focus is epidemiology of sleep and psychiatric disorders in the general population and clinical settings: 1)sleep habits and patterns; 2) prevalence, diagnosis, co-morbidity, treatment and Public Health impact of sleep disorders; 3) pain, posttraumatic stress disorder, social phobia, panic disorder and generalized anxiety; 4) epidemiology of narcolepsy and hypersomnia.
-
Nichole Olson
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Nichole Olson is a Clinical Assistant Professor and licensed psychologist in the INSPIRE Clinic and Dialectical Behavior Therapy (DBT) program at Stanford. Dr. Olson completed her masters and doctorate degrees at Northwestern University in Chicago and finished her postdoctoral fellowship at Stanford University. Dr. Olson specializes in evidence-based, recovery-oriented care for individuals with psychosis, providing both individual and group Cognitive Behavioral Therapy for Psychosis (CBTp) to adults within the INSPIRE Clinic. In addition, Dr. Olson leads trainings and ongoing consultation for providers learning to implement CBTp. As a clinician and Assistant Director of Stanford’s DBT program, Dr. Olson also provides individual DBT treatment for those with emotion regulation difficulties.
-
Nnamdi Orakpo, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Nnamdi Orakpo is a fellowship-trained sleep medicine specialist with Stanford Health Care. Dr. Orakpo is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine at Stanford University School of Medicine.
Dr. Orakpo specializes in sleep medicine and sleep psychiatry. He focuses on sleep-related conditions, including chronic insomnia, narcolepsy, sleep apnea, restless leg syndrome, and trauma-associated sleep disorders. Dr. Orakpo also treats patients with ADHD, depression, anxiety disorders, neurocognitive disorders, and post-traumatic stress disorder. He offers interventional psychiatry treatments, including ketamine therapy and transcranial magnetic stimulation.
Dr. Orakpo led a pioneering study on virtual reality neurofeedback to treat insomnia and chronic centralized pain. He has also studied managing sleep apnea and obesity using GLP-1 medications. His other research has looked at the development of a rare movement disorder (propriospinal myoclonus) after taking metoclopramide during pregnancy.
Dr. Orakpo has published his research in peer-reviewed journals, including Sleep, Frontiers in Human Neuroscience, and Frontiers in Psychiatry. He co-wrote a clinical sleep medicine textbook with his colleagues, contributing chapters on chronic insomnia, isolated sleep paralysis, sleep-related eating disorders, sexsomnia, and exploding head syndrome. Dr. Orakpo has presented to his peers at international and national meetings of the World Sleep Congress/World Dentofacial Sleep Society, the American Academy of Neurology, and the American Public Health Association.
Dr. Orakpo is a member of many professional organizations, including the American Academy of Sleep Medicine, the American Psychiatric Association, the North American Neuromodulation Society, and the World Sleep Society. -
Karen Osilla
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsDr. Osilla conducts health services research with a focus on supporting families impacted by substance use. Dr. Osilla has been conducting addictions research since 2006 and has been involved in clinical trials evaluating cognitive behavioral therapy, collaborative care, and motivational interviewing interventions (web and in-person) among youth, adult, military, family members, and other hard-to-reach populations.
-
Michael Ostacher
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Ostacher is Professor of Psychiatry and Behavioral Sciences. He is the Site Director for the Addiction Medicine Fellowship at the VA Palo Alto Health Care System, where he also serves as the Medical Director of the Pharmacology of Addiction Recovery Clinic, the Director of the Bipolar and Depression Research Program and the Co-Director of the VA/Stanford Exploratory Therapeutics Lab, the Director of Advanced Fellowship Training in Mental Illness Research and Treatment for MDs for the VISN 21 MIRECC, and the Site Director at the VA Palo Alto for Advanced Fellowship Training for Stanford. A graduate of Vanderbilt University School of Medicine, the Harvard School of Public Health, and Harvard Medical School, he completed his training at The Cambridge Health Alliance at Harvard Medical School in Adult Psychiatry, Public Psychiatry, and Geriatric Psychiatry, and is currently board certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine. He is the Digital Content Editor for the journal Evidence-Based Mental Health and is on the editorial boards of Bipolar Disorders, the International Journal of Bipolar Disorders, the Journal of Clinical Psychiatry, Current Psychiatry, and Psychiatric Annals. His current research includes roles as Site Investigator for VA-BRAVE, multicenter, randomized trial comparing long-acting injectable buprenorphine to sublingual buprenorphine/naloxone, and trials of psychedelic drugs in psychiatric disorders in Veterans. With funding from NIDA, he studied, along with Jaimee Heffner, Ph.D. at the Fred Hutchinson Cancer Research Center in Seattle, smoking cessation in people with bipolar disorder using a novel online psychotherapy derived from Acceptance and Commitment Therapy. His work using a Capnometry Guided Respiratory Intervention (CGRI) for PTSD led to the FDA clearance for Freespira, a digital therapeutic, for the treatment of PTSD. His primary research interest is in large clinical trials mental health and addiction, and the implementation of evidence-based mental health practices.
